Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: LeMaitre Vascular Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
CVRx Inc. June 4, 202488.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 1, 2026 | CVRx Inc. | Grant or award | +8,720 | — | — |
| Feb 26, 2026 | LeMaitre Vascular Inc. | Grant or award | +476 | — | — |
| Feb 26, 2026 | LeMaitre Vascular Inc. | Option exercise | +1 | — | — |
| Dec 12, 2025 | LeMaitre Vascular Inc. | Option exercise | +5 | — | — |
| Dec 12, 2025 | LeMaitre Vascular Inc. | Option exercise | +5 | — | — |
| Dec 10, 2025 | LeMaitre Vascular Inc. | Grant or award | +533 | — | — |
| Dec 8, 2025 | LeMaitre Vascular Inc. | Option exercise | +2 | — | — |
| Dec 8, 2025 | LeMaitre Vascular Inc. | Option exercise | +3 | — | — |
| Dec 6, 2025 | LeMaitre Vascular Inc. | Option exercise | +1 | — | — |
| Feb 28, 2025 | LeMaitre Vascular Inc. | Grant or award | +204 | — | — |
| Feb 28, 2025 | LeMaitre Vascular Inc. | Option exercise | +1 | — | — |
| Dec 12, 2024 | LeMaitre Vascular Inc. | Option exercise | +3 | — | — |
| Dec 12, 2024 | LeMaitre Vascular Inc. | Option exercise | +3 | — | — |
| Dec 9, 2024 | LeMaitre Vascular Inc. | Option exercise | +1 | — | — |
| Dec 6, 2024 | LeMaitre Vascular Inc. | Grant or award | +420 | — | — |
Questions about Martha Shadan
What boards is Martha Shadan on?
Martha Shadan sits on the boards of CVRx Inc. and LeMaitre Vascular Inc.
How long has Martha Shadan served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.